We are live on
!
Find out more
BBA
Baker Bros. Advisors Portfolio holdings
AUM
$17.4B
1-Year Est. Return
131.5%
This Fund
S&P 500
This Quarter
Est. Return
+2.27%
1 Year Est. Return
+131.5%
3 Year Est. Return
+336.81%
5 Year Est. Return
+553.16%
10 Year Est. Return
+4,134.93%
AUM
$17.4B
AUM Growth
+$337M
(+2%)
Cap. Flow
+$511M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
73.49%
Holding
93
New
8
Increased
18
Reduced
6
Closed
9
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
+$194M |
| 2 |
GRAL
GRAIL Inc
GRAL
|
+$151M |
| 3 |
Insmed
INSM
|
+$127M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
+$42M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
+$31.4M |
Top Sells
| 1 |
Ultragenyx Pharmaceutical
RARE
|
+$63.8M |
| 2 |
Immunocore
IMCR
|
+$51.4M |
| 3 |
TERN
Terns Pharmaceuticals
TERN
|
+$38.4M |
| 4 |
BioNTech
BNTX
|
+$25.6M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$22M |
Sector Composition
| 1 | Healthcare | 99.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBRX
76
LB Pharmaceuticals
LBRX
$930M
| $4.93M | 0.03% |
200,000
| – | – |
|
77
Verastem
VSTM
$510M
| $3.1M | 0.02% |
+584,757
| New | +$3.61M |
|
78
TScan Therapeutics
TCRX
$60.8M
| $2.81M | 0.02% |
2,784,792
| – | – |
|
79
Skye Bioscience
SKYE
$21.9M
| $968K | 0.01% |
1,575,243
+124,605
| +9% | +$102K |
|
80
Sana Biotechnology
SANA
$1.01B
| $894K | 0.01% |
310,483
| – | – |
|
81
Aligos Therapeutics
ALGS
$38.4M
| $617K | ﹤0.01% |
83,055
| – | – |
|
82
Tyra Biosciences
TYRA
$1.93B
| $406K | ﹤0.01% |
10,607
| – | – |
|
83
Surrozen Inc Warrant
SRZNW
| $13.3K | ﹤0.01% |
833,333
| – | – |
|
84
Acrivon Therapeutics
ACRV
$90.3M
| – | – |
-22,809
| Closed | -$55K |
|
|
85
BioCryst Pharmaceuticals
BCRX
$2.5B
| – | – |
-2,822,727
| Closed | -$22M |
|
86
4D Molecular Therapeutics
FDMT
$616M
| – | – |
-475,737
| Closed | -$3.57M |
|
87
KALA BIO
KALA
$20.1M
| – | – |
-36,081
| Closed | -$1M |
|
88
Nuvalent
NUVL
$9.81B
| – | – |
-143,937
| Closed | -$14.5M |
|
|
89
Ultragenyx Pharmaceutical
RARE
$3.19B
| – | – |
-2,772,692
| Closed | -$63.8M |
|
|
TERN
90
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-950,000
| Closed | -$38.4M |
|
91
Vir Biotechnology
VIR
$1.62B
| – | – |
-542,539
| Closed | -$3.27M |
|
|
VTYX
92
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-2,349,280
| Closed | -$21.2M |
|
Similar funds
MCM
ASRS
PP
CS
SFA
VMPIC
LA
BCIM